Disputing issues in the paradigm change to finite antiviral therapy in HBeAg-negative patients

Wen Juei Jeng; Rong Nan Chien; Yun Fan Liaw

doi:10.1016/j.jhep.2021.06.027

Disputing issues in the paradigm change to finite antiviral therapy in HBeAg-negative patients

Wen Juei Jeng
, Rong Nan Chien
, Yun Fan Liaw^*

^*Corresponding author for this work

Chang Gung Memorial Hospital

Research output: Contribution to journal › Journal Letter › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	1498-1499
Number of pages	2
Journal	Journal of Hepatology
Volume	75
Issue number	6
DOIs	https://doi.org/10.1016/j.jhep.2021.06.027
State	Published - 12 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

HBsAg loss
hepatitis flare
relapse
retreatment

Access to Document

10.1016/j.jhep.2021.06.027

Cite this

@article{868988357bea48e7bc11a3f396d27e4f,

title = "Disputing issues in the paradigm change to finite antiviral therapy in HBeAg-negative patients",

keywords = "HBsAg loss, hepatitis flare, relapse, retreatment",

author = "Jeng, \{Wen Juei\} and Chien, \{Rong Nan\} and Liaw, \{Yun Fan\}",

year = "2021",

month = dec,

doi = "10.1016/j.jhep.2021.06.027",

language = "英语",

volume = "75",

pages = "1498--1499",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier B.V.",

number = "6",

}

TY - JOUR

T1 - Disputing issues in the paradigm change to finite antiviral therapy in HBeAg-negative patients

AU - Jeng, Wen Juei

AU - Chien, Rong Nan

AU - Liaw, Yun Fan

PY - 2021/12

Y1 - 2021/12

KW - HBsAg loss

KW - hepatitis flare

KW - relapse

KW - retreatment

UR - https://www.scopus.com/pages/publications/85115778575

U2 - 10.1016/j.jhep.2021.06.027

DO - 10.1016/j.jhep.2021.06.027

M3 - 快报

C2 - 34214616

AN - SCOPUS:85115778575

SN - 0168-8278

VL - 75

SP - 1498

EP - 1499

JO - Journal of Hepatology

JF - Journal of Hepatology

IS - 6

ER -

Disputing issues in the paradigm change to finite antiviral therapy in HBeAg-negative patients

UN SDGs

Keywords

Access to Document

Other files and links

Cite this